Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains three supplements: daidzein and genistein (isoflavones found in soy) and palmitoylethanolamide (PEA), an endogenous fatty acid amide. These are often used for their purported anti-inflammatory and analgesic properties.
## Primary Indications
* **Symptomatic relief of chronic pain and inflammation.** This is an off-label use as evidence for these specific indications and this combination is limited.
## Adult Dosing
* Dosing varies widely depending on the product and intended use. Common regimens include:
* Daidzein: 20-50 mg orally once or twice daily.
* Genistein: 20-50 mg orally once or twice daily.
* Palmitoylethanolamide (PEA): 300-1200 mg orally once or twice daily.
* Specific combination product dosing should follow manufacturer recommendations.
## Pediatric Dosing
* No established pediatric dosing. Use in pediatric populations is not recommended due to lack of safety and efficacy data.
## Dose Adjustments
* No specific dose adjustments for renal or hepatic impairment are established due to its supplement nature.
## Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding (due to lack of safety data).
* Hormone-sensitive conditions (e.g., certain breast cancers, uterine fibroids) due to the potential estrogenic activity of isoflavones.
## Adverse Effects
* **Daidzein/Genistein:** Gastrointestinal upset (nausea, diarrhea, abdominal pain), headache, and potential hormonal effects.
* **Palmitoylethanolamide (PEA):** Generally well-tolerated. May include gastrointestinal upset.
## Key Drug Interactions
* **Hormonal Therapies:** Potential for additive or antagonistic effects with estrogen replacement therapy or anti-estrogen medications.
* **Warfarin:** Isoflavones may theoretically affect vitamin K metabolism, although clinical significance is unclear. Monitor INR if co-administered.
## Monitoring
* Monitor for adverse effects.
* For patients with hormone-sensitive conditions, monitor for any signs of disease progression.
## Clinical Pearls
* The efficacy and safety of this combination for specific indications are not well-established by rigorous clinical trials.
* It is crucial to verify the exact composition and concentration of each component in the specific product being used.
* Patients should be advised that these are supplements and do not replace conventional medical therapy.
***
**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider to determine the appropriateness of any medication or treatment for your specific condition and to review the most up-to-date prescribing information.
